over her right shoulder since1 month. Initially small gradually progressed to the present size of approximately 3×4 cms. No history of pain or trauma. No history of tingling sensations and no h/o difficulty in limb movements. No history of fever or nausea or vomiting. No history of other swellings in the body.
On examination, A well-defined ~ 4×3 cms swelling is seen over anterior part of right shoulder. Skin over the swelling appears normal. Non-tender and there was no local rise of temperature, firm to hard in consistency, and was mobile. Skin over the swelling was pinchable. No restriction of hand movements. No lymphadenopathy. Systemic examination was within normal limits.
On X-ray of right shoulder was normal. USG was significant other thick walled well defined lesion, neurogenic tumour. FNAC was significant other giant cell lesion of soft tissue.
Following which patient was taken up for wide local excisional biopsy. HPE of the excision biopsy was significant other epithelioid sarcoma with faint focal positivity for pancytokeratin and EMA and negative for LCA, CK-3 and S-100 with free margins.
Medical oncologist opinion was taken in view of the HPE report, was advised to get evaluated for metatstasis and to undergo radiotherapy.
On further evaluation, USG of abdomen and pelvis showed no abnormalities. HRCT thorax significant other ill-defined small sub pleural nodule (3 mm) in anterior segment of right upper lobe. Following which she had undergone radiotherapy, as per medical oncologist advice.
DISCUSSION
Epithelioid sarcoma (ES) is a rare, high-grade malignancy that represents the most common primary soft tissue sarcomas of the hand. It is classified under tumour of uncertain histiogenesis.
It was first described by Enzinger in 1970, typically presenting as a subcutaneous nodule or deep dermal mass in the distal extrimities. 2 Proximal variant was first described in 1997 by Guillou et al. 5 Incidence is 0.04/million/yearin 2005 with male: female ratio being 1.8:1,with females having better prognosis.
It is divided into two variants: distal and proximal
Proximal where the former is more common and less aggressive of the two. The most common primary site for epithelioid sarcomas is distal upper extremities followed by distal lower extremities and proximal extremities. It has a tendency to spread by lymphatics with, metastatic rate of 45%, of which more common are to lung. Recurrence rate is reported to be 77%. Loss of INI1 (aka hSNF5 and SMARCB1) has been seen in 80% of epitheloid sarcomas. 4 MRI is the modality of choice for diagnosis prior to biopsy and pathologic diagnosis as it helps in determining anatomic boundaries. Also helps in differentiating recurrence from postoperative changes after multiple excisions.
Immunohistochemical studies have shown that vimentin reactivity is present in almost all cases. Cytokeratin AE1/AE3 and epithelial membrane antigen were positive in 96% and 98% of the cases respectively. There is consistent staining for CA-125, and some have suggested using it as a serum marker to monitor for metastasis. 6 Negative S100 is typical (distinguishing it from malignant peripheral nerve sheath tumor), endothelial markers (distinguishing it from epithelioid angiosarcoma), CK5/6 (distinguishing it from squamous cell carcinoma). 6 CD34 is expressed in 50-60% of epithelioid sarcomas, but is negative in carcinomas, helping to distinguish the two. P63 is also a useful marker that is present in virtually all squamous cell carcinomas, but absent in epithelioid sarcomas. 6 Wide surgical resection remains the most recommended treatment modality. Epithelioid sarcoma has recurrence rates of up to 77% after marginal resection in some longterm studies. It has also been noted to spread proximally in the same limb, distant to the original tumor (so-called "local metastasis").
Amputation can be considered if there are multiple recurrences or if there is not a significant loss of function (like a fingertip). However, it does not seem to help with "local metastasis" control.
Role of adjuvants
As epithelioid sarcoma is rare and slow growing, makes it difficult to have long term follow up to find significant difference between different adjuvant treatment methods. Radiation therapy is used in some institutions for primary and recurrent cases for limb salvage, with favorable results compared to amputation. 7 The late effects (scarring, stiffness, and neuropathy) can be particularly debilitating in the hand. Chemotherapy (doxorubicin) has been used for multifocal, large (>5 cm), or metastatic disease. It has not been shown to improve survivorship. The better prognostic factors includes younger age at presentation, female gender, smaller size <2 cm, site at distal extremities, stage of the disease, low mitotic index.
CONCLUSION
Epithelioid sarcoma is a rare malignant soft tissue tumour with high rate of recurrence and metastasis. Diagnosis may be delayed due to its benign appearance in presentation in the initial stage of the disease. Tissue diagnosis with immunohistochemical typing remains the diagnostic investigation of choice. Treatment includes surgical resection combined with radiotherapy and adjuvant chemotherapy.
